Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

ProPhase Labs (PRPH) Enterprise Value (2016 - 2025)

Historic Enterprise Value for ProPhase Labs (PRPH) over the last 16 years, with Q3 2025 value amounting to -$405000.0.

  • ProPhase Labs' Enterprise Value rose 6297.99% to -$405000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$405000.0, marking a year-over-year increase of 6297.99%. This contributed to the annual value of -$678000.0 for FY2024, which is 8568.41% up from last year.
  • Per ProPhase Labs' latest filing, its Enterprise Value stood at -$405000.0 for Q3 2025, which was up 6297.99% from -$171000.0 recorded in Q2 2025.
  • ProPhase Labs' 5-year Enterprise Value high stood at -$88000.0 for Q1 2025, and its period low was -$36.3 million during Q1 2021.
  • Moreover, its 5-year median value for Enterprise Value was -$9.1 million (2023), whereas its average is -$13.8 million.
  • Per our database at Business Quant, ProPhase Labs' Enterprise Value plummeted by 225901.11% in 2021 and then skyrocketed by 9493.09% in 2025.
  • Quarter analysis of 5 years shows ProPhase Labs' Enterprise Value stood at -$17.2 million in 2021, then decreased by 1.45% to -$17.4 million in 2022, then skyrocketed by 72.84% to -$4.7 million in 2023, then soared by 85.68% to -$678000.0 in 2024, then soared by 40.27% to -$405000.0 in 2025.
  • Its Enterprise Value was -$405000.0 in Q3 2025, compared to -$171000.0 in Q2 2025 and -$88000.0 in Q1 2025.